ABBV logo

AbbVie (ABBV) Net Income

Annual Net Income

$4.28 B
-$585.00 M-12.03%

December 1, 2024


Summary


Performance

ABBV Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABBVprofitabilitymetrics:

Quarterly Net Income

-$22.00 M
-$1.58 B-101.41%

December 1, 2024


Summary


Performance

ABBV Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABBVprofitabilitymetrics:

TTM Net Income

$4.28 B
-$844.00 M-16.48%

December 1, 2024


Summary


Performance

ABBV TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABBVprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

ABBV Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-12.0%-101.4%-16.5%
3 y3 years-62.9%-102.4%-66.2%
5 y5 years-45.7%-100.8%-45.7%

ABBV Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-63.9%at low-100.5%at low-68.1%at low
5 y5-year-63.9%at low-100.5%+97.0%-68.1%at low
alltimeall time-63.9%+141.2%-100.5%+98.8%-68.1%+491.5%

AbbVie Net Income History

DateAnnualQuarterlyTTM
Dec 2024
$4.28 B(-12.0%)
-$22.00 M(-101.4%)
$4.28 B(-16.5%)
Sep 2024
-
$1.56 B(+13.9%)
$5.12 B(-4.1%)
Jun 2024
-
$1.37 B(+0.1%)
$5.34 B(-10.9%)
Mar 2024
-
$1.37 B(+66.5%)
$5.99 B(+23.2%)
Dec 2023
$4.86 B(-58.9%)
$822.00 M(-53.8%)
$4.86 B(-25.3%)
Sep 2023
-
$1.78 B(-12.2%)
$6.51 B(-25.0%)
Jun 2023
-
$2.02 B(+746.9%)
$8.69 B(+14.5%)
Mar 2023
-
$239.00 M(-90.3%)
$7.58 B(-35.9%)
Dec 2022
$11.84 B(+2.5%)
$2.47 B(-37.4%)
$11.84 B(-11.7%)
Sep 2022
-
$3.95 B(+327.4%)
$13.41 B(+6.1%)
Jun 2022
-
$924.00 M(-79.4%)
$12.64 B(+1.3%)
Mar 2022
-
$4.49 B(+11.0%)
$12.48 B(+8.1%)
Dec 2021
$11.54 B(+150.0%)
$4.04 B(+27.2%)
$11.54 B(+53.2%)
Sep 2021
-
$3.18 B(+315.0%)
$7.53 B(+13.1%)
Jun 2021
-
$766.00 M(-78.4%)
$6.66 B(+29.2%)
Mar 2021
-
$3.55 B(+9769.4%)
$5.16 B(+11.8%)
Dec 2020
$4.62 B(-41.4%)
$36.00 M(-98.4%)
$4.62 B(-37.5%)
Sep 2020
-
$2.31 B(-412.7%)
$7.38 B(+6.1%)
Jun 2020
-
-$738.00 M(-124.5%)
$6.96 B(-17.5%)
Mar 2020
-
$3.01 B(+7.5%)
$8.44 B(+7.0%)
Dec 2019
$7.88 B(+38.6%)
$2.80 B(+48.7%)
$7.88 B(+142.2%)
Sep 2019
-
$1.88 B(+154.3%)
$3.25 B(-21.0%)
Jun 2019
-
$741.00 M(-69.8%)
$4.12 B(-23.2%)
Mar 2019
-
$2.46 B(-234.5%)
$5.36 B(-5.7%)
Dec 2018
$5.69 B(+7.1%)
-$1.83 B(-166.5%)
$5.69 B(-24.8%)
Sep 2018
-
$2.75 B(+38.5%)
$7.57 B(+17.3%)
Jun 2018
-
$1.98 B(-28.7%)
$6.45 B(+1.1%)
Mar 2018
-
$2.78 B(+5251.9%)
$6.38 B(+20.2%)
Dec 2017
$5.31 B
$52.00 M(-96.8%)
$5.31 B(-20.1%)
DateAnnualQuarterlyTTM
Sep 2017
-
$1.63 B(-14.8%)
$6.65 B(+0.5%)
Jun 2017
-
$1.92 B(+11.9%)
$6.62 B(+4.8%)
Mar 2017
-
$1.71 B(+23.0%)
$6.31 B(+6.0%)
Dec 2016
$5.95 B(+15.7%)
$1.39 B(-13.0%)
$5.95 B(-2.1%)
Sep 2016
-
$1.60 B(-0.7%)
$6.08 B(+6.3%)
Jun 2016
-
$1.61 B(+18.9%)
$5.72 B(+4.5%)
Mar 2016
-
$1.35 B(-10.7%)
$5.48 B(+6.5%)
Dec 2015
$5.14 B(+190.0%)
$1.52 B(+22.4%)
$5.14 B(+82.6%)
Sep 2015
-
$1.24 B(-9.3%)
$2.82 B(+35.2%)
Jun 2015
-
$1.37 B(+33.7%)
$2.08 B(+14.8%)
Mar 2015
-
$1.02 B(-226.2%)
$1.82 B(+2.4%)
Dec 2014
$1.77 B(-57.0%)
-$810.00 M(-260.1%)
$1.77 B(-52.2%)
Sep 2014
-
$506.00 M(-53.9%)
$3.71 B(-11.0%)
Jun 2014
-
$1.10 B(+12.0%)
$4.17 B(+0.7%)
Mar 2014
-
$980.00 M(-13.1%)
$4.14 B(+0.3%)
Dec 2013
$4.13 B(-21.7%)
$1.13 B(+17.0%)
$4.13 B(-9.1%)
Sep 2013
-
$964.00 M(-9.7%)
$4.54 B(-12.0%)
Jun 2013
-
$1.07 B(+10.3%)
$5.16 B(-3.7%)
Mar 2013
-
$968.00 M(-37.1%)
$5.36 B(+1.6%)
Dec 2012
$5.28 B(+53.7%)
$1.54 B(-2.8%)
$5.28 B(+7.8%)
Sep 2012
-
$1.58 B(+25.1%)
$4.89 B(+47.4%)
Jun 2012
-
$1.27 B(+43.5%)
$3.32 B(-7.6%)
Mar 2012
-
$883.00 M(-23.7%)
$3.59 B(+4.7%)
Dec 2011
$3.43 B(-17.8%)
$1.16 B(+9283.3%)
$3.43 B(+50.9%)
Sep 2011
-
$12.34 M(-99.2%)
$2.28 B(+0.5%)
Jun 2011
-
$1.54 B(+112.9%)
$2.26 B(+212.9%)
Mar 2011
-
$723.20 M
$723.20 M
Dec 2010
$4.18 B(-9.9%)
-
-
Dec 2009
$4.64 B
-
-

FAQ

  • What is AbbVie annual net profit?
  • What is the all time high annual net income for AbbVie?
  • What is AbbVie annual net income year-on-year change?
  • What is AbbVie quarterly net profit?
  • What is the all time high quarterly net income for AbbVie?
  • What is AbbVie quarterly net income year-on-year change?
  • What is AbbVie TTM net profit?
  • What is the all time high TTM net income for AbbVie?
  • What is AbbVie TTM net income year-on-year change?

What is AbbVie annual net profit?

The current annual net income of ABBV is $4.28 B

What is the all time high annual net income for AbbVie?

AbbVie all-time high annual net profit is $11.84 B

What is AbbVie annual net income year-on-year change?

Over the past year, ABBV annual net profit has changed by -$585.00 M (-12.03%)

What is AbbVie quarterly net profit?

The current quarterly net income of ABBV is -$22.00 M

What is the all time high quarterly net income for AbbVie?

AbbVie all-time high quarterly net profit is $4.49 B

What is AbbVie quarterly net income year-on-year change?

Over the past year, ABBV quarterly net profit has changed by -$1.58 B (-101.41%)

What is AbbVie TTM net profit?

The current TTM net income of ABBV is $4.28 B

What is the all time high TTM net income for AbbVie?

AbbVie all-time high TTM net profit is $13.41 B

What is AbbVie TTM net income year-on-year change?

Over the past year, ABBV TTM net profit has changed by -$844.00 M (-16.48%)